Airo Brands, a US multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC, has received regulatory approval for its CE-marked Class IIa medical handheld liquid inhalation device, the Airo Medical Inhalation System, across Europe and Australia.
This planned launch will introduce the second EU-certified device of its kind, designed specifically for the delivery of cannabinoid-based medicines under strict medical standards.
This milestone will mark the entry of a precision-engineered device into regulated medical markets, supported by a strategic partnership with SOMAÍ, which will manufacture EU-GMP inhalation oils and serve as the exclusive global distributor for the system’s cartridge line and API’s.
more
